• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经纤维瘤病1型通过miR-142-5p靶向髓细胞白血病-1蛋白来调节卵巢癌细胞的凋亡。

NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142-5p.

作者信息

Su Jiancheng, Ruan Shaolin, Dai Shengkun, Mi Jing, Chen Wei, Jiang Songshan

机构信息

Department of Biological Sciences & Technology, School of Life Sciences, Sun Yat-sen University, Guangzhou, PR China.

Department of Gynecology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, PR China.

出版信息

Pharmacogenomics. 2019 Feb;20(3):155-165. doi: 10.2217/pgs-2018-0161. Epub 2018 Dec 13.

DOI:10.2217/pgs-2018-0161
PMID:30543142
Abstract

AIM

NF1 loss confers chemoresistance in multiple cancers. However, the etiology remains largely unknown. Our study aimed to scrutinize the role of NF1 in chemoresistant ovarian cancer and its underlying mechanism.

MATERIALS & METHODS: 4',6-diamidino-2-phenylindole staining, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay, luciferase reporter assay, chromatin immunoprecipitation, Western blot, quantitative real-time-PCR and rescue experiments were performed to illustrate the antiapoptotic role of NF1 loss and its underlying mechanism.

RESULTS

NF1-knockdown ovarian cells showed resistance to cisplatin-induced apoptosis. Furthermore, NF1 regulated MCL1 expression at protein level. Further dissections suggested that miR-142-5p was regulated by NF1 via its promoter and targeted MCL1. Consistently, miR-142-5p mimic and si-MCL1 can attenuate the antiapoptotic effect of NF1 knockdown.

CONCLUSION

NF1 knockdown endowed ovarian cells with resistance to cisplatin-induced apoptosis by targeting MCL1 via miR-142-5p.

摘要

目的

神经纤维瘤病1型(NF1)缺失在多种癌症中赋予化疗耐药性。然而,其病因在很大程度上仍不清楚。我们的研究旨在探究NF1在化疗耐药性卵巢癌中的作用及其潜在机制。

材料与方法

进行4',6-二脒基-2-苯基吲哚染色、末端脱氧核苷酸转移酶介导的dUTP缺口末端标记检测、荧光素酶报告基因检测、染色质免疫沉淀、蛋白质免疫印迹、定量实时聚合酶链反应及挽救实验,以阐明NF1缺失的抗凋亡作用及其潜在机制。

结果

NF1基因敲低的卵巢癌细胞对顺铂诱导的凋亡具有抗性。此外,NF1在蛋白质水平上调节髓细胞白血病序列1(MCL1)的表达。进一步分析表明,微小RNA-142-5p(miR-142-5p)由NF1通过其启动子进行调控,并靶向MCL1。一致地,miR-142-5p模拟物和MCL1小干扰RNA(si-MCL1)可减弱NF1基因敲低的抗凋亡作用。

结论

NF1基因敲低通过miR-142-5p靶向MCL1,赋予卵巢细胞对顺铂诱导凋亡的抗性。

相似文献

1
NF1 regulates apoptosis in ovarian cancer cells by targeting MCL1 via miR-142-5p.神经纤维瘤病1型通过miR-142-5p靶向髓细胞白血病-1蛋白来调节卵巢癌细胞的凋亡。
Pharmacogenomics. 2019 Feb;20(3):155-165. doi: 10.2217/pgs-2018-0161. Epub 2018 Dec 13.
2
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.miR-142-5p 通过靶向多个抗凋亡基因增强卵巢癌细胞对顺铂的凋亡作用。
Biochem Pharmacol. 2019 Mar;161:98-112. doi: 10.1016/j.bcp.2019.01.009. Epub 2019 Jan 11.
3
miR-509-3p promotes cisplatin-induced apoptosis in ovarian cancer cells through the regulation of anti-apoptotic genes.miR-509-3p通过调控抗凋亡基因促进顺铂诱导的卵巢癌细胞凋亡。
Pharmacogenomics. 2017 Dec;18(18):1671-1682. doi: 10.2217/pgs-2017-0115. Epub 2017 Nov 27.
4
microRNA-137 downregulates MCL1 in ovarian cancer cells and mediates cisplatin-induced apoptosis.微小RNA-137下调卵巢癌细胞中的髓细胞白血病-1(MCL1)并介导顺铂诱导的细胞凋亡。
Pharmacogenomics. 2020 Feb;21(3):195-207. doi: 10.2217/pgs-2019-0122.
5
MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells.微小RNA-155促进SKOV3、A2780和原代培养的卵巢癌细胞凋亡。
Tumour Biol. 2016 Jul;37(7):9289-99. doi: 10.1007/s13277-016-4804-9. Epub 2016 Jan 15.
6
MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells.微小RNA-106a靶向髓细胞白血病序列1以抑制卵巢癌A2780细胞的顺铂耐药性。
J Huazhong Univ Sci Technolog Med Sci. 2013 Aug;33(4):567-572. doi: 10.1007/s11596-013-1160-5. Epub 2013 Aug 1.
7
Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.通过靶向C-Jun恢复卵巢癌中的miR-139-5p可逆转顺铂耐药性。
Cell Physiol Biochem. 2018;51(1):129-141. doi: 10.1159/000495169. Epub 2018 Nov 15.
8
miR-194-5p inhibits SLC40A1 expression to induce cisplatin resistance in ovarian cancer.miR-194-5p 通过抑制 SLC40A1 表达诱导卵巢癌细胞对顺铂耐药。
Pathol Res Pract. 2020 Jul;216(7):152979. doi: 10.1016/j.prp.2020.152979. Epub 2020 Apr 28.
9
MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells.miR-34a-5p/PD-L1 轴调节卵巢癌细胞的顺铂化疗耐药性。
Neoplasma. 2020 Jan;67(1):93-101. doi: 10.4149/neo_2019_190202N106. Epub 2019 Nov 26.
10
MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2.miR-335-5p 通过靶向 BCL2L2 恢复卵巢癌细胞对顺铂的敏感性。
Cancer Med. 2018 Sep;7(9):4598-4609. doi: 10.1002/cam4.1682. Epub 2018 Jul 17.

引用本文的文献

1
Clinicopathologic Characteristics and Prognostic Profile of Chronic Myeloid Neoplasms With Somatic NF1 Mutations in Adult Patients.成年患者伴有体细胞NF1突变的慢性髓系肿瘤的临床病理特征及预后分析
Eur J Haematol. 2025 Jul;115(1):46-56. doi: 10.1111/ejh.14419. Epub 2025 Mar 28.
2
IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner.IGF2BP3 通过 m6A 依赖方式介导 NF1 的 mRNA 降解,促进三阴性乳腺癌进展。
Clin Transl Med. 2023 Sep;13(9):e1427. doi: 10.1002/ctm2.1427.
3
Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
载脂蛋白 B mRNA 编辑酶催化多肽 3 介导的突变在乳腺癌中的临床意义。
Clin Cancer Res. 2023 May 1;29(9):1658-1669. doi: 10.1158/1078-0432.CCR-22-2861.
4
Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.优化的甲状腺转录因子-1 核心启动子驱动的 microRNA-7 表达可有效抑制人非小细胞肺癌细胞的生长。
J Zhejiang Univ Sci B. 2022 Nov 15;23(11):915-930. doi: 10.1631/jzus.B2200116.
5
Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment.BCL2 家族的转录特征可用于个体化急性髓系白血病治疗。
Genome Med. 2022 Sep 28;14(1):111. doi: 10.1186/s13073-022-01115-w.
6
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.全面综述微小 RNA 在卵巢癌化疗耐药中的作用;最新综述。
J Ovarian Res. 2022 Jul 7;15(1):81. doi: 10.1186/s13048-022-01012-1.
7
Evaluation of NF1 and RASA1 gene expression in endometriosis.子宫内膜异位症中NF1和RASA1基因表达的评估。
Eur J Obstet Gynecol Reprod Biol X. 2022 May 4;15:100152. doi: 10.1016/j.eurox.2022.100152. eCollection 2022 Aug.
8
Altered Expressions of NF1 and NF1-Related microRNAs as Biomarkers in the Diagnosis of Undifferentiated Pleomorphic Sarcoma.NF1及NF1相关微小RNA的表达改变作为未分化多形性肉瘤诊断生物标志物的研究
Front Genet. 2022 Apr 26;13:870191. doi: 10.3389/fgene.2022.870191. eCollection 2022.
9
Doxorubicin-induced novel circRNA_0004674 facilitates osteosarcoma progression and chemoresistance by upregulating MCL1 through miR-142-5p.阿霉素诱导产生的新型环状RNA_0004674通过miR-142-5p上调MCL1促进骨肉瘤进展和化疗耐药。
Cell Death Discov. 2021 Oct 23;7(1):309. doi: 10.1038/s41420-021-00694-8.
10
The Non-Coding RNAs Inducing Drug Resistance in Ovarian Cancer: A New Perspective for Understanding Drug Resistance.非编码RNA诱导卵巢癌耐药:理解耐药性的新视角
Front Oncol. 2021 Sep 30;11:742149. doi: 10.3389/fonc.2021.742149. eCollection 2021.